Issue 03: The fatigue nobody measured
A Sjögren's drug moved the fatigue number, what the drug under FDA review did and did not show, and the CAR-T pause, explained plainly.
- Sjögren's
- Lupus
- Rheumatoid arthritis
- MS
- All conditions
The newsletter
Since your last appointment.
Our weekly newsletter on new treatments, trials, and findings in autoimmune disease, in plain language, so you walk into your next appointment better prepared. Every story is sourced and linked. Free.
Past issues
3 issues shown
Issue 02: a few things worth knowing
Combining biologics for refractory disease, an MS first for kids, a first-ever treatment, and a plain way to make sense of new research.
- Ankylosing spondylitis
- IBD
- MS
- Lupus
- Rheumatoid arthritis
- Sjögren's
- All conditions
Inaugural issue: a big year in autoimmune
A big year in autoimmune: what "resetting" the immune system means, a first for Sjögren's, a new lupus option, and more.
- Lupus
- Sjögren's
- IBD
- MS
- Rheumatoid arthritis
- All conditions